Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 6 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Squamous-Cell Lung Cancer 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1 NSCLC 1 Melanoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Carboplatin 134 Paclitaxel 122 Bevacizumab 69 Gemcitabine 37 Taxes 36 liposomal doxorubicin 33 Cisplatin 30 pembrolizumab 29 Topotecan 27 olaparib 21 Cyclophosphamide 21 Specimen Handling 19 Immunoglobulin G 19 Disulfides 19 Drug Therapy 17 Docetaxel 17 Magnetic Resonance Spectroscopy 15 Doxorubicin 14 Biopsy 14 niraparib 13 mirvetuximab soravtansine 13 Hyperthermic Intraperitoneal Chemotherapy 12 Nivolumab 11 rucaparib 10 Cytoreduction Surgical Procedures 10 Chemotherapy, Adjuvant 10 Platinum 8 Neoadjuvant Therapy 8 Albumin-Bound Paclitaxel 8 veliparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡